Presentation
17 March 2023 Test method for evaluating the photocytotoxic potential of fluorescence imaging products
Author Affiliations +
Abstract
Contrast-enhanced fluorescent imaging has the potential to improve patient outcomes. A critical challenge that has not been rigorously evaluated is the potential photocytoxicity of the fluorophores used for imaging procedures. In this study, we have used a modified 3T3 Neutral Red Uptake assessment strategy to evaluate 4 imaging dyes and 2 known photosensitizers generating reactive molecular species. Results shed light on the relative photocytotoxicity of tested agents and provide strong evidence on the effectiveness of the method. These methods will provide a foundation for standardizing photo-safety testing of clinical fluorescence imaging products.
Conference Presentation
© (2023) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Shruti Vig, Brandon Gaitan, Lucas Frankle, Miriam Adwan, Yu Chen, Rosalie Elespuru, Joshua Pfefer, and Huang-Chiao Huang "Test method for evaluating the photocytotoxic potential of fluorescence imaging products", Proc. SPIE PC12359, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XXXI, PC1235908 (17 March 2023); https://doi.org/10.1117/12.2652255
Advertisement
Advertisement
KEYWORDS
Luminescence

Safety

In vitro testing

Molecules

Skin

Standards development

Tissues

Back to Top